Exchange: NASDAQ
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 5/24/2012
Last 10 Quotes:
What's This?
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.93 | -0.28 | -433.51 |
| EPS, GAAP | 0.93 | -0.28 | -0.28 |
| Consensus Estimate | 0.84 | -0.28 | -398.54 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | -1.41 | -1.41 | 20.81 |
| EPS, GAAP | -1.41 | -1.41 | 20.81 |
| Consensus Estimate | -1.34 | -1.19 | 12.21 |
| THRX | Industry Average | |
| P/E (TTM) | 0.00 | NA |
| P/E (Forward) | 0.00 | NA |
| PEG Ratio | 0.00 | 2.17 |
| Price/Sales | 12.34 | 4.18 |
| Beta | 1.18 | 0.62 |
| 4/2/2012 | Stocks in the Spotlight Monday (Barrons.com) |
| 4/2/2012 | Willbros Group, Theravance: Biggest Price Gainers (WG, THRX) (WSJ.com) |
| 4/2/2012 | Theravance Jumps on Glaxo Investment (THRX, GSK) (24/7 Wall St) |
| 4/2/2012 | Glaxo Lifts Theravance Stake (WSJ.com) |
| 3/29/2012 | Next up, getting patients to switch. (The Motley Fool) |
![[sm061210things]](http://s.wsj.net/public/resources/images/PF-AC562_sm0612_C_20120514113337.jpg)
![[sm0612wedding4]](http://s.wsj.net/public/resources/images/PF-AC579_sm0612_C_20120515172853.jpg)
![[sm0612strat]](http://s.wsj.net/public/resources/images/PF-AC580_sm0612_C_20120515180019.jpg)
![[sm0612roi]](http://s.wsj.net/public/resources/images/PF-AC573_sm0612_C_20120515125902.jpg)
